Zenara Pharma gets CDSCO nod to make generic version of Pfizer Covid pill

Hyderabad-based Zenara Pharma, a fully owned subsidiary of Biophore India Pharmaceuticals, has announced that it has received approval from the Central Drugs Standard Control Organization (CDSCO) to manufacture and sell Nirmatrelvir and Ritonavir tablets in a combi pack as a treatment option for patients with mild to moderate symptoms of Covid-19.

The tablet, which will be sold under the brand name 'Paxzen', is being manufactured at Zenara's USFDA approved state-of-the- art facility in Hyderabad.

For more details, check out the full story on the link below:

Biophore India Pharma Arm Gets CDSCO Nod To Manufacture, Sell Generic Version Of Pfizer COVID Drug Paxlovid